Clinical Trial Update: Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema [Phase 3]

View source ↗

Summary

Phase 3 trial results show efficacy and safety of ranibizumab given by intravitreal injections in patients with visual impairment due to diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Novartis | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2012-10-18